{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:06:59Z","timestamp":1771218419142,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The development of recurrent ischemic priapism (RIP) is associated with mental health disorders, psychiatric medications, and substance use, but the temporal relationship between the onset of RIP and the development of these risk factors is poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This study aimed to investigate the chronology of psychosocial and substance use risk factors relative to the initial clinical presentation of RIP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of 73 adult patients diagnosed with RIP at a single academic center, identified via manual chart review of the electronic health record. Patients presenting with RIP between 2004 and 2020 were included, with data collection extending to 2025 to ensure a minimum follow-up of nearly 5 years for all participants to minimize censoring bias and capture delayed risk factor onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>The date of the first RIP presentation (index event) was compared to the first documented date of several risk factors, including anxiety, depression, psychiatric medication use, and substance use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the overall cohort, there was no statistically significant difference in the proportion of any risk factor developing before versus after the onset of RIP. Further, in a sub-analysis of 35 patients with sickle cell disease (SCD), a higher proportion of patients initiated psychiatric medication after the onset of RIP, although this was not statistically significant (P\u2009=\u2009.0522). No other factors reached statistical significance in the SCD sub-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical implications<\/jats:title>\n                    <jats:p>The findings suggest that RIP may be a psychologically traumatic event that contributes to the development of the same psychosocial risk factors it is associated with.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Strengths and limitations<\/jats:title>\n                    <jats:p>The primary strength of this study is its novel investigation into the temporal relationship between RIP and psychosocial risk factors, supported by a design that ensured a minimum follow-up period of over 4 years for all participants. Limitations are primarily related to its retrospective, single-center chart-review design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest a complex, potentially bidirectional relationship that highlights the need for integrated mental health screening for all patients with RIP, particularly for the high-risk SCD population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/sexmed\/qfag005","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T12:37:17Z","timestamp":1769863037000},"source":"Crossref","is-referenced-by-count":0,"title":["Exploring the temporal relationship between psychosocial risk factors and recurrent ischemic priapism"],"prefix":"10.1093","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7406-6077","authenticated-orcid":false,"given":"Devin M","family":"Dishong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Essien","sequence":"additional","affiliation":[{"name":"Department of Urology, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuezhou","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Urology, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6560-8605","authenticated-orcid":false,"given":"Arthur L","family":"Burnett","sequence":"additional","affiliation":[{"name":"Department of Urology, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"2","key":"2026021523265609200_ref1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ucl.2011.02.005","article-title":"Priapism: new concepts in medical and surgical management","volume":"38","author":"Burnett","year":"2011","journal-title":"Urol Clin N Am"},{"issue":"4","key":"2026021523265609200_ref2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ucl.2007.08.006","article-title":"Priapism: current principles and practice","volume":"34","author":"Burnett","year":"2007","journal-title":"Urol Clin N Am"},{"issue":"1","key":"2026021523265609200_ref3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/ju.0000000000002767","article-title":"The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and non-ischemic priapism: an AUA\/SMSNA guideline","volume":"208","author":"Bivalacqua","year":"2022","journal-title":"J Urol"},{"key":"2026021523265609200_ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41443-025-01026-5","article-title":"Update on the prevalence and pathophysiology of sickle cell priapism: a narrative review","volume":"11","author":"Akakpo","year":"2025","journal-title":"Int J Impot Res"},{"issue":"7","key":"2026021523265609200_ref5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/j.1464-410x.2011.10367.x","article-title":"Treating stuttering priapism","volume":"108","author":"Kheirandish","year":"2011","journal-title":"BJU Int"},{"issue":"9","key":"2026021523265609200_ref6","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1046\/j.1464-410x.2002.03022.x","article-title":"Priapism in sickle-cell disease; incidence, risk factors and complications\u2014an international multicentre study","volume":"90","author":"Adeyoju","year":"2002","journal-title":"BJU Int"},{"key":"2026021523265609200_ref7","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/j.urology.2021.06.010","article-title":"Priapism and sickle cell disease: special considerations in etiology, management, and prevention","volume":"156","author":"Ahuja","year":"2021","journal-title":"Urology."},{"issue":"4","key":"2026021523265609200_ref8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.amjsurg.2010.03.017","article-title":"Priapism in the United States: the changing role of sickle cell disease","volume":"201","author":"Chrouser","year":"2011","journal-title":"Am J Surg"},{"issue":"6","key":"2026021523265609200_ref9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/s0022-5347(05)68812-x","article-title":"Cocaine associated priapism","volume":"161","author":"Altman","year":"1999","journal-title":"J Urol"},{"issue":"3","key":"2026021523265609200_ref10","doi-asserted-by":"publisher","DOI":"10.54143\/jbmede.v4i3.129","article-title":"Intoxica\u00e7\u00e3o por coca\u00edna resultando em priapismo isqu\u00eamico: um relato de Caso e revis\u00e3o da literatura","volume":"4","author":"Mensch","year":"2024","journal-title":"JBMEDE."},{"issue":"1","key":"2026021523265609200_ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-020-0015-8","article-title":"Recurrent priapism in the setting of cannabis use","volume":"2","author":"Montgomery","year":"2020","journal-title":"J Cannabis Res"},{"issue":"6","key":"2026021523265609200_ref12","doi-asserted-by":"publisher","first-page":"e13013","DOI":"10.1111\/and.13013","article-title":"A new cause of ischaemic priapism: synthetic cannabinoids","volume":"50","author":"Ortac","year":"2018","journal-title":"Andrologia."},{"issue":"3","key":"2026021523265609200_ref13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000475058","article-title":"Aetiology of priapism in207 patients","volume":"28","author":"Kulmala","year":"1995","journal-title":"Eur Urol"},{"key":"2026021523265609200_ref14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/20451253221113246","article-title":"Risperidone-induced priapism: a case report and literature review","volume":"12","author":"Ateb","year":"2022","journal-title":"Ther Adv Psychopharmacol"},{"issue":"3","key":"2026021523265609200_ref15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.sxmr.2020.10.003","article-title":"A review of antipsychotics and priapism","volume":"9","author":"Hwang","year":"2021","journal-title":"Sex Med Rev"},{"key":"2026021523265609200_ref16","doi-asserted-by":"publisher","first-page":"e88603","DOI":"10.7759\/cureus.88603","article-title":"Trazodone-induced ischemic priapism successfully managed with conservative therapy: a case report","volume":"17","author":"Szymkiewicz","year":"2025","journal-title":"Cureus"},{"key":"2026021523265609200_ref17","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.09l00816gry","article-title":"Penile amputation after trazodone-induced priapism: a case report","volume":"22","author":"Hoffmann","year":"2010","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"1","key":"2026021523265609200_ref18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1176\/appi.ajp-rj.2023.190105","article-title":"Trazodone-induced priapism and increased recurrence risk with antipsychotics","volume":"19","author":"Eisenach","year":"2023","journal-title":"AJP Residents\u2019 J"},{"issue":"6","key":"2026021523265609200_ref19","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1111\/j.1743-6109.2009.01246.x","article-title":"Anxiety disorders in patients with idiopathic priapism: risk factor and pathophysiologic link?","volume":"6","author":"Burnett","year":"2009","journal-title":"J Sex Med"},{"issue":"7","key":"2026021523265609200_ref20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/pch\/pxy113","article-title":"ADHD in children and youth: part 2\u2014treatment","volume":"23","author":"Feldman","year":"2018","journal-title":"Paediatr Child Health"},{"key":"2026021523265609200_ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/672624","article-title":"Priapism: comorbid factors and treatment outcomes in a contemporary series","volume":"2012","author":"Gottsch","year":"2012","journal-title":"Adv Urol"},{"issue":"8","key":"2026021523265609200_ref22","doi-asserted-by":"publisher","first-page":"e1118","DOI":"10.1097\/mph.0000000000001998","article-title":"Stuttering priapism in a teenage boy: lesson to be learnt","volume":"43","author":"Sachdeva","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"2026021523265609200_ref23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/1742395307081505","article-title":"The physical, social and psychological impact of priapism on adult males with sickle cell disorder","volume":"3","author":"Addis","year":"2007","journal-title":"Chronic Illn"},{"issue":"1","key":"2026021523265609200_ref24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/mph.0000000000002056","article-title":"Psychometric impact of priapism on lives of adolescents and adults with sickle cell Anemia: a sequential independent mixed-methods design","volume":"44","author":"Idris","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"2026021523265609200_ref25","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.urology.2015.02.025","article-title":"Priapism impact profile questionnaire: development and initial validation","volume":"85","author":"Burnett","year":"2015","journal-title":"Urology."},{"issue":"47","key":"2026021523265609200_ref26","doi-asserted-by":"publisher","first-page":"e36147","DOI":"10.1097\/MD.0000000000036147","article-title":"Psychosocial challenges of persons with sickle cell anemia: a narrative review","volume":"102","author":"Essien","year":"2023","journal-title":"Medicine (Baltimore)"}],"container-title":["Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/14\/1\/qfag005\/66919647\/qfag005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/14\/1\/qfag005\/66919647\/qfag005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T04:27:03Z","timestamp":1771216023000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smoa\/article\/doi\/10.1093\/sexmed\/qfag005\/8487142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,30]]}},"URL":"https:\/\/doi.org\/10.1093\/sexmed\/qfag005","relation":{},"ISSN":["2050-1161"],"issn-type":[{"value":"2050-1161","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,30]]},"article-number":"qfag005"}}